Episode Details

The Supreme Court has ruled in favor of the governments ability to negotiate Medicare drug prices with drug companies, a significant win for the administrations healthcare spending control efforts. This decision upholds the Inflation Reduction Act of 2022, which allows the government to negotiate prices for expensive Medicare drugs, starting in 2026. Despite Republican opposition and drug company resistance, the government is moving forward with negotiations for twenty-five drugs, including popular weight-loss and diabetes medications. The law has no expiration date, making it difficult for drug companies to halt the program without congressional intervention.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/fb5d5a0f6db68d9d